Found: 27
Select item for more details and to access through your institution.
Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01164-x
- By:
- Publication type:
- Article
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01159-8
- By:
- Publication type:
- Article
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00888-6
- By:
- Publication type:
- Article
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00883-x
- By:
- Publication type:
- Article
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
- By:
- Publication type:
- Article
Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population‐based cohort study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. E197, doi. 10.1002/ajh.26957
- By:
- Publication type:
- Article
Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0120749
- By:
- Publication type:
- Article
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 5, p. 815, doi. 10.1111/ejh.14082
- By:
- Publication type:
- Article
Colon perforation in multiple myeloma patients – A complication of high‐dose steroid treatment.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8895, doi. 10.1002/cam4.3507
- By:
- Publication type:
- Article
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1166038
- By:
- Publication type:
- Article
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. e227, doi. 10.1016/j.clml.2024.02.006
- By:
- Publication type:
- Article
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. e104, doi. 10.1016/j.clml.2023.11.008
- By:
- Publication type:
- Article
P-140: Monoclonal proteinuria ≥200 mg/24h predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S111, doi. 10.1016/S2152-2650(21)02267-9
- By:
- Publication type:
- Article
OAB-037: Assessing the prognostic utility of the Mayo 2018 and IMWG 2020 smoldering multiple myeloma risk stratification scores applied post diagnosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02111-X
- By:
- Publication type:
- Article
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
An atlas of the bone marrow bone proteome in patients with dysproteinemias.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00840-8
- By:
- Publication type:
- Article
An atlas of the bone marrow bone proteome in patients with dysproteinemias.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00840-8
- By:
- Publication type:
- Article
Second- and third-line treatment strategies in multiple myeloma: a referral-center experience.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00757-8
- By:
- Publication type:
- Article
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00659-9
- By:
- Publication type:
- Article
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 11, p. 1, doi. 10.1038/s41408-021-00569-2
- By:
- Publication type:
- Article
Relapsed multiple myeloma demonstrates distinct patterns of immune microenvironment and malignant cell-mediated immunosuppression.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00440-4
- By:
- Publication type:
- Article
Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 12, p. 1, doi. 10.1038/s41408-020-00391-2
- By:
- Publication type:
- Article
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00353-8
- By:
- Publication type:
- Article
The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 306, doi. 10.1007/s11899-022-00682-4
- By:
- Publication type:
- Article
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E35, doi. 10.1002/ajh.26023
- By:
- Publication type:
- Article
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. 519, doi. 10.1093/oncolo/oyae041
- By:
- Publication type:
- Article
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database.
- Published in:
- EJHaem, 2022, v. 3, n. 4, p. 1252, doi. 10.1002/jha2.559
- By:
- Publication type:
- Article